Sintx Technologies, Inc.

NasdaqCM SINT

Sintx Technologies, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 1.33

Sintx Technologies, Inc. Price to Sales Ratio (P/S) is 1.33 on January 14, 2025, a -94.08% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Sintx Technologies, Inc. 52-week high Price to Sales Ratio (P/S) is 22.44 on January 16, 2024, which is 1,590.53% above the current Price to Sales Ratio (P/S).
Sintx Technologies, Inc. 52-week low Price to Sales Ratio (P/S) is 0.84 on November 15, 2024, which is -36.45% below the current Price to Sales Ratio (P/S).
Sintx Technologies, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 3.99.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqCM: SINT

Sintx Technologies, Inc.

CEO	Mr. Eric K. Olson
IPO Date	Feb. 13, 2014
Location	United States
Headquarters	1885 West 2100 South
Employees	43
Sector	Materials
Industries Chemicals & Advanced Materials Pharmaceuticals Semiconductors

Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Key trends

Past 5 years